Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Benoit

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research|May 15, 2025
Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenocarcinoma CellsMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Cancer Research|June 3, 2004
A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cellsMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Surgery|August 10, 2004
RETRACTED: Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancerMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Biochemical and Biophysical Research Communications|November 19, 2003
RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivityMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Oncogene|July 19, 2023
Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasivenessMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Surgery|February 11, 2023
Retraction notice to Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase (RRM2): a novel therapeutic strategy in pancreatic cancer [Surgery 136 (2004) 261-269]Mark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Oncogene|June 23, 2004
Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasivenessMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Cancer Research|May 15, 2025
Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2Hiromichi Ito, Mark Duxbury, Eric Benoit, et al.
Cancer Research|October 20, 2004
RETRACTED: Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2Hiromichi Ito, Mark Duxbury, Eric Benoit, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 18, 2009
Impact of radiologic intervention on mortality in necrotizing pancreatitis: the role of organ failureFlavio G Rocha, Eric Benoit, Michael J Zinner, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|May 15, 2025
Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenocarcinoma CellsMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Cancer Research|June 3, 2004
A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cellsMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Surgery|August 10, 2004
RETRACTED: Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancerMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Biochemical and Biophysical Research Communications|November 19, 2003
RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivityMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Oncogene|July 19, 2023
Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasivenessMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Surgery|February 11, 2023
Retraction notice to Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase (RRM2): a novel therapeutic strategy in pancreatic cancer [Surgery 136 (2004) 261-269]Mark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Oncogene|June 23, 2004
Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasivenessMark S Duxbury, Hiromichi Ito, Eric Benoit, et al.
Cancer Research|May 15, 2025
Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2Hiromichi Ito, Mark Duxbury, Eric Benoit, et al.
Cancer Research|October 20, 2004
RETRACTED: Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2Hiromichi Ito, Mark Duxbury, Eric Benoit, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 18, 2009
Impact of radiologic intervention on mortality in necrotizing pancreatitis: the role of organ failureFlavio G Rocha, Eric Benoit, Michael J Zinner, et al.
Pageof 3